Our news
ºÚÁϳԹÏÍø's CEO Presents at Morgan Stanley 23rd Annual Global Healthcare Conference | September 2025
ºÚÁϳԹÏÍø's CEO - Michael Shih - recently presented the ºÚÁϳԹÏÍø story at the Morgan Stanley Global Healthcare Conference on Monday September 8th…
Neophore appoints Michael Shih as Chief Executive Officer
ºÚÁϳԹÏÍø appoints Michael Shih as Chief Executive Officer • Highly experienced corporate development leader with a track record of international p…
ºÚÁϳԹÏÍø closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
ºÚÁϳԹÏÍø closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore…
ºÚÁϳԹÏÍø presented preclinical data from our PMS2 program at the AACR Annual Meeting, San Diego, 5 - 10 April 2024.
The ºÚÁϳԹÏÍø team attended the American Association for Cancer Research Annual Meeting in San Diego, 5 - 10 April 2024. In collaboration with The…
Other news
CEO Jeff Roix spoke to BioCentury about how ºÚÁϳԹÏÍø Ltd is developing small molecules to inhibit DNA mismatch repair (MMR) and create a pool of…
APM Health: Interview with CEO, Jeff Roix
Scrip Emerging company profile: UK-based ºÚÁϳԹÏÍø, founded in 2017, is developing novel cancer therapies based on DNA-repair technology. The company…